Docusign (NASDAQ:DOCU) Posts Earnings Results, Beats Estimates By $0.24 EPS

Share on StockTwits

Docusign (NASDAQ:DOCU) released its quarterly earnings results on Thursday. The company reported $0.01 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.24, Briefing.com reports. Docusign had a negative net margin of 28.20% and a negative return on equity of 25.64%. The company had revenue of $235.61 million for the quarter, compared to analyst estimates of $220.81 million. During the same period last year, the firm earned $0.03 earnings per share. The firm’s revenue was up 41.0% on a year-over-year basis. Docusign updated its Q3 2020 guidance to EPS and its FY 2020 guidance to EPS.

Shares of DOCU stock opened at $56.27 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 1.00. Docusign has a 52 week low of $35.06 and a 52 week high of $59.67. The firm’s 50-day simple moving average is $47.86 and its two-hundred day simple moving average is $52.25.

In related news, Director Peter Solvik sold 541,532 shares of Docusign stock in a transaction that occurred on Tuesday, July 9th. The shares were sold at an average price of $51.52, for a total value of $27,899,728.64. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Kirsten O. Wolberg sold 7,877 shares of Docusign stock in a transaction that occurred on Tuesday, June 25th. The stock was sold at an average price of $50.93, for a total transaction of $401,175.61. The disclosure for this sale can be found here. Insiders sold a total of 560,988 shares of company stock worth $28,915,981 in the last ninety days. 13.60% of the stock is currently owned by insiders.

Several research firms have commented on DOCU. William Blair reissued an “outperform” rating on shares of Docusign in a research report on Friday, June 7th. Zacks Investment Research cut shares of Docusign from a “buy” rating to a “hold” rating in a research report on Monday, July 29th. Wedbush raised shares of Docusign from a “neutral” rating to an “outperform” rating and lifted their target price for the stock from $48.00 to $65.00 in a research report on Friday. Royal Bank of Canada initiated coverage on Docusign in a report on Friday. They set an “outperform” rating and a $75.00 price target on the stock. Finally, JPMorgan Chase & Co. lifted their price target on Docusign from $88.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday. Three analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $64.33.

About Docusign

DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.

Further Reading: What is the Coverage Ratio?

Earnings History for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nanometrics  Lifted to Hold at BidaskClub
Nanometrics Lifted to Hold at BidaskClub
Nasdaq  Downgraded by BidaskClub
Nasdaq Downgraded by BidaskClub
NetScout Systems  Raised to “Hold” at BidaskClub
NetScout Systems Raised to “Hold” at BidaskClub
Intellia Therapeutics  Raised to Hold at BidaskClub
Intellia Therapeutics Raised to Hold at BidaskClub
Northern Trust  Lifted to “Hold” at BidaskClub
Northern Trust Lifted to “Hold” at BidaskClub
Liberty Latin America  Upgraded at BidaskClub
Liberty Latin America Upgraded at BidaskClub


© 2006-2019 Ticker Report